Suppr超能文献

使用吸入性倍氯米松和氟替卡松的哮喘患者的皮肤瘀斑、肾上腺功能及骨代谢标志物

Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.

作者信息

Malo J L, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet L P

机构信息

Dept of Chest Medicine, Hôpital du Sacré-Coeur, Montréal, Québec, Canada.

出版信息

Eur Respir J. 1999 May;13(5):993-8. doi: 10.1034/j.1399-3003.1999.13e11.x.

Abstract

Fluticasone propionate (FP) is generally considered to have twice the efficacy of beclomethasone dipropionate (BDP) on a weight-to-weight basis for the control of asthma, and may have lesser effects on adrenal function. However, the effects of FP and BDP on skin integrity and bone metabolism markers require further examination. Sixty-nine asthmatic subjects were enrolled in a double-blind crossover study in which, after a baseline period, they received BDP or FP (at half the dose of BDP) for two 4-month periods each. A questionnaire on skin bruising, a skin examination, tests of adrenal function and of markers of bone metabolism were performed after 2 months of each period. The number of asthma exacerbations was not significantly different for the two treatment periods (eight for BDP and nine for FP), nor were various indices of asthma control. Whereas the frequency of bruising reported by the questionnaire was not different, there were more bruises on examination for BDP (1.6+/-2.5) than for FP (1.2+/-2.3) (p=0.04). Although baseline serum cortisol was not significantly different for the two drugs, the increase in cortisol after cortrosyn was lower for BDP (357+/-158 micromol x dL(-1)) than for FP (422+/-144 micromol x dL(-1)) (p<0.01). Serum osteocalcin levels were significantly lower in subject on BDP (2.8+/-1.7 microg x mL(-1)) than on FP (3.5+/-1.9 ng x mL(-1)) (p=0.003). Other markers of bone metabolism were not significantly altered. The three major side-effects were loosely, but significantly correlated with the periods on BDP and FP. However, skin bruises, increase in cortisol after Cortrosyn and osteocalcin were not significantly correlated for the period on either BDP or FP. In conclusion, whereas fluticasone propionate used at half the dose of beclomethasone dipropionate has a comparable effect on the control of asthma, fluticasone propionate demonstrated fewer side-effects in terms of skin bruising, adrenal suppression and bone metabolism.

摘要

丙酸氟替卡松(FP)在控制哮喘方面,按重量计算其疗效一般被认为是二丙酸倍氯米松(BDP)的两倍,并且对肾上腺功能的影响可能较小。然而,FP和BDP对皮肤完整性和骨代谢标志物的影响需要进一步研究。69名哮喘患者参与了一项双盲交叉研究,在基线期后,他们分别接受BDP或FP(剂量为BDP的一半)治疗,各为期4个月,共两个周期。在每个周期的2个月后,进行了关于皮肤瘀伤的问卷调查、皮肤检查、肾上腺功能测试和骨代谢标志物测试。两个治疗周期的哮喘加重次数无显著差异(BDP组8次,FP组9次),哮喘控制的各项指标也无差异。虽然问卷调查中报告的瘀伤频率无差异,但检查发现BDP组的瘀伤(1.6±2.5处)比FP组(1.2±2.3处)更多(p = 0.04)。虽然两种药物的基线血清皮质醇无显著差异,但BDP组在促皮质素刺激后皮质醇的升高幅度(357±158 μmol·dL⁻¹)低于FP组(422±144 μmol·dL⁻¹)(p<0.01)。BDP组患者的血清骨钙素水平(2.8±1.7 μg·mL⁻¹)显著低于FP组(3.5±1.9 ng·mL⁻¹)(p = 0.003)。其他骨代谢标志物无显著变化。这三种主要副作用与使用BDP和FP的周期有大致但显著的相关性。然而,在使用BDP或FP的周期中,皮肤瘀伤、促皮质素刺激后皮质醇升高和骨钙素之间无显著相关性。总之,虽然丙酸氟替卡松使用二丙酸倍氯米松一半的剂量对哮喘控制有类似效果,但丙酸氟替卡松在皮肤瘀伤、肾上腺抑制和骨代谢方面的副作用较少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验